Sung-Hwan Cho
Chief Executive Officer at CHOA PHARMACEUTICAL CO., LTD.
Net worth: 2 M $ as of 2024-04-29
Sung-Hwan Cho active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CHOA PHARMACEUTICAL CO., LTD. | Director/Board Member | 2002-02-17 | - |
| Chief Executive Officer | - | - | |
| President | - | - | |
Medipharm
 Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Chief Executive Officer | - | - |
| President | - | - |
Career history of Sung-Hwan Cho
Training of Sung-Hwan Cho
| Korea University | Undergraduate Degree |
| Chung-Ang University | Graduate Degree |
Statistics
International
| South Korea | 5 |
Operational
| President | 2 |
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CHOA PHARMACEUTICAL CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Medipharm
Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Distribution Services |
- Stock Market
- Insiders
- Sung-Hwan Cho
- Experience
